- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01963806
ACT-smart: Smartphone-supplemented iCBT for Social Phobia and/or Panic Disorder
Guided and Unguided CBT for Social Anxiety Disorder and/or Panic Disorder Via the Internet and a Smartphone Application
BACKGROUND: Smartphone technology presents a novel and promising opportunity to extend the reach of psychotherapeutic interventions by moving selected parts of the therapy into the real-life situations causing distress. This randomised controlled trial will investigate the effect of a transdiagnostic, Internet-administered cognitive behavioural (iCBT) self-help program for anxiety, supplemented with a tailored smartphone application. The effect of added therapist support will also be studied.
METHODS/DESIGN: 150 participants meeting diagnostic criteria for social anxiety disorder and/or panic disorder will be evenly randomised to one of three treatment arms: (1) smartphone-supplemented iCBT with therapist support; (2) smartphone-supplemented iCBT without therapist support; or (3) an active waiting list control group with delayed treatment. After the 10 week treatment period, the control group (3) will receive the same treatment as group (2). Primary outcome measure will be the Generalised Anxiety Disorder 7-item self-rating scale. Secondary measures include other anxiety, depression and quality of life measures. In addition to pre- and post-treatment measurements, the study includes two mid-treatment and two follow-up assessments (12 and 24 months).
HYPOTHESES: Based on prior research, we hypothesise that the therapist-guided form will be superior to the unguided form in reducing anxiety levels, and that both delivery modes will be superior to an active waiting-list control group.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden
- Stockholm University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Satisfy DSM-IV-TR criteria for panic disorder and/or social anxiety disorder as assessed by the SCID.
- Daily access to the Internet via computer and smartphone
- Residing in Sweden and speaking sufficient Swedish to communicate with the research team
Exclusion Criteria:
- Parallel psychological treatment
- Non-stable dosage of psychoactive medication during last 3 months
- Participants deemed to suffer from suicidal tendencies or another condition requiring specialized treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Smartphone-supplemented iCBT with therapist support
n = 50
|
The Internet-administered cognitive behavioural self-help program (iCBT) will be divided into 10 weekly, progressively available modules covering CBT and Acceptance and Commitment Therapy (ACT) conceptualisations of anxiety disorders, as well as more specific therapeutic techniques such as cognitive restructuring, exposure training, attention and breathing exercises and relapse prevention . Each module also includes writing exercises. Also included is a tailored smartphone application. Briefly, the application allows the user to access, create and modify a personal database of behaviours and check-off these behaviours immediately when completed. Frequency of carried-out behaviours are recorded and displayed as statistics. The application also allows users to browse and search a database of behaviours uploaded by other study participants, providing both inspiration and a sense of social support.
The role of the therapists will be to provide feedback on the written exercises of each treatment module, as well as to provide support and encouragement.
As a rule of thumb, the therapists will devote 15 minutes per participant and week.
|
Experimental: Smartphone-supplemented iCBT without therapist support
n = 50
|
The Internet-administered cognitive behavioural self-help program (iCBT) will be divided into 10 weekly, progressively available modules covering CBT and Acceptance and Commitment Therapy (ACT) conceptualisations of anxiety disorders, as well as more specific therapeutic techniques such as cognitive restructuring, exposure training, attention and breathing exercises and relapse prevention . Each module also includes writing exercises. Also included is a tailored smartphone application. Briefly, the application allows the user to access, create and modify a personal database of behaviours and check-off these behaviours immediately when completed. Frequency of carried-out behaviours are recorded and displayed as statistics. The application also allows users to browse and search a database of behaviours uploaded by other study participants, providing both inspiration and a sense of social support. |
Active Comparator: Active waiting list control group with delayed treatment
n = 50
|
The Internet-administered cognitive behavioural self-help program (iCBT) will be divided into 10 weekly, progressively available modules covering CBT and Acceptance and Commitment Therapy (ACT) conceptualisations of anxiety disorders, as well as more specific therapeutic techniques such as cognitive restructuring, exposure training, attention and breathing exercises and relapse prevention . Each module also includes writing exercises. Also included is a tailored smartphone application. Briefly, the application allows the user to access, create and modify a personal database of behaviours and check-off these behaviours immediately when completed. Frequency of carried-out behaviours are recorded and displayed as statistics. The application also allows users to browse and search a database of behaviours uploaded by other study participants, providing both inspiration and a sense of social support.
Completes measurements at day 24 and 48 and at the end of the initial treatment period, otherwise no activity until crossover.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Generalised Anxiety Disorder 7-item (GAD-7)
Time Frame: Change from baseline at: [1] day 24 and [2] day 48 into the 10-week treatment period; [3] 0-1 week after the treatment period; follow-ups at [4] month 12 and [5] month 36 after the treatment period.
|
The Generalised Anxiety Disorder 7-item (GAD-7).
The 7 items of the scales are rated 0-3 ("Not at all" to "Nearly every day") based on their occurrence within the last 2 weeks.
Good internal consistency and factor structure has been reported.
|
Change from baseline at: [1] day 24 and [2] day 48 into the 10-week treatment period; [3] 0-1 week after the treatment period; follow-ups at [4] month 12 and [5] month 36 after the treatment period.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Self-rated Liebowitz Social Anxiety Scale (LSAS-SR)
Time Frame: Change from baseline at: [1] 0-1 week after the treatment period; follow-ups at [2] month 12 and [3] month 36 after the treatment period.
|
Change from baseline at: [1] 0-1 week after the treatment period; follow-ups at [2] month 12 and [3] month 36 after the treatment period.
|
Self-rated Panic Disorder Severity Scale (PDSS-SR)
Time Frame: Change from baseline at: [1] 0-1 week after the treatment period; follow-ups at [2] month 12 and [3] month 36 after the treatment period.
|
Change from baseline at: [1] 0-1 week after the treatment period; follow-ups at [2] month 12 and [3] month 36 after the treatment period.
|
9-item Patient Health Questionnaire (PHQ-9)
Time Frame: Change from baseline at: [1] day 24 and [2] day 48 into the 10-week treatment period; [3] 0-1 week after the treatment period; follow-ups at [4] month 12 and [5] month 36 after the treatment period.
|
Change from baseline at: [1] day 24 and [2] day 48 into the 10-week treatment period; [3] 0-1 week after the treatment period; follow-ups at [4] month 12 and [5] month 36 after the treatment period.
|
Quality of Life Inventory (QOLI)
Time Frame: Change from baseline at: [1] 0-1 week after the treatment period; follow-ups at [2] month 12 and [3] month 36 after the treatment period.
|
Change from baseline at: [1] 0-1 week after the treatment period; follow-ups at [2] month 12 and [3] month 36 after the treatment period.
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ACT-smart
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Phobic Disorders
-
Duke UniversityBaylor College of Medicine; Yale University; Icahn School of Medicine at Mount... and other collaboratorsCompletedANXIETY DISORDERS (or Anxiety and Phobic Neuroses)United States
-
University Hospital TuebingenUnknown
-
VU University of AmsterdamCompletedPhobic DisordersNetherlands
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Southern Methodist UniversityCompletedPhobic DisordersUnited States
-
Connor, Kathryn M., M.D.Forest LaboratoriesCompleted
-
University Hospital, MontpellierLuc Nicon, Education Specialist, Founder of "Tipi", a non-profit French associationCompleted
-
Ecole Polytechnique Fédérale de LausanneUniversity Hospital, GenevaNot yet recruiting
-
Central Hospital, Nancy, FranceRecruitingClaustrophobiaFrance
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedPhobic DisordersNorway
Clinical Trials on Smartphone-supplemented iCBT
-
University of ReginaCanadian Institutes of Health Research (CIHR)Completed
-
Vastra Gotaland RegionCompletedAnxiety Disorders and Symptoms | Internet-Based InterventionSweden
-
University of ReginaCompletedDepression | Anxiety | Chronic DiseaseCanada
-
Karolinska InstitutetRegion StockholmCompletedGeneralized Anxiety DisorderSweden
-
Linkoeping UniversityCompleted
-
Federico II UniversityMead Johnson NutritionCompleted
-
Karolinska InstitutetRegion StockholmCompletedInternet-based Cognitive Behavioral Therapy for Adolescents With Sleep Problems- a Feasibility TrialDepressive Disorder | Inflammation | Anxiety Disorders | Pain, Chronic | Insomnia DisorderSweden
-
Linkoeping UniversityStockholm UniversityCompletedGeneralized Anxiety DisorderSweden
-
The University of Hong KongRecruitingStroke | Depressive Symptoms | Mobile Phone UseHong Kong
-
The University of Hong KongCompletedStroke | Depressive Symptoms | Mobile Phone UseHong Kong